Autologous and Donor-derived CD7 CAR-T Therapy in Refractory or Relapsed T-cell Acute Lymphoblastic Leukemia/Lymphoma

Conditions: T-cell Acute Lymphoblastic Leukemia; Acute Lymphoblastic Leukemia, in Relapse; Refractory Acute Lymphoblastic Leukemia Interventions: Drug: Autologous CD7 CAR T-cell; Drug: Prior-HSCT donor-derived CD7 CAR T-cell; Drug: New donor-derived CD7 CAR T-cell Sponsors: Beijing GoBroad Hospital Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials